This is a Phase 1/2 study in patients presenting with any solid tumor and/or diseased tissue
even benign nodules presumed to be resectable and at risk for recurrence on pre-operative
assessment who are considered to be good surgical candidates to evaluate the safety and
efficacy of the image-guided surgery using indocyanine green for intramolecular imaging of
solid tumors.